Skip to Main Content
Contribute Try STAT+ Today

WASHINGTON — Rep. Kurt Schrader, the Oregon Democrat who has played an outsized role in shaping his party’s new drug pricing compromise, is still pushing for changes to the proposal ahead of a key vote on the legislation expected as soon as this week.

Schrader and a number of other Democrats are meeting Wednesday to discuss their proposed changes to the ultimate package, he said, hinting that moderates like Reps. Scott Peters (D-Calif.) and Kathleen Rice (D-N.Y.) could be in attendance. He declined to lay out the full list of meeting attendees.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment